Upgrades:
Merck & Co., Inc. (NYSE:MRK) was upgraded by stock analysts at Erste Group Bank from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Thursday, The Fly reports.
MRK has been the topic of a number of other research
reports. UBS Group boosted their price objective on shares of Merck & Co.,
Inc. from $76.00 to $98.00 and gave the stock a "neutral" rating in a
report on Monday, July 18th. Atlantic Securities upped their price target on
shares of Merck & Co., Inc. from $105.00 to $110.00 and gave the company an
"overweight" rating in a research report on Wednesday, July 13th.
Cowen raised their target price on shares of Merck & Co., Inc. from $95.00
to $102.00 and gave the company a "market perform" rating in a
research note on Monday, June 27th. Mizuho began coverage on shares of Merck
& Co., Inc. in a report on Friday, June 24th. They set a "buy"
rating and a $100.00 price objective for the company. Finally, Morgan Stanley
lifted their price target on shares of Merck & Co., Inc. from $88.00 to
$92.00 and gave the stock an "equal weight" rating in a research
report on Friday, July 29th. Eight analysts have rated the stock with a hold
rating, ten have issued a buy rating and two have assigned a strong buy rating
to the company. According to MarketBeat, the stock has an average rating of
"Moderate Buy" and a consensus price target of $97.44. Read
more …
Toronto-Dominion Bank (NYSE:TD) (TSE:TD) was upgraded by equities research analysts at Royal Bank of Canada from a “sector perform” rating to an “outperform” rating in a research note issued to investors on Friday, The Fly reports.
Other equities analysts have also issued research reports
about the stock. CIBC lowered their price objective on shares of
Toronto-Dominion Bank from C$100.00 to C$97.00 in a research report on Tuesday,
August 16th. National Bank Financial increased their price objective on shares
of Toronto-Dominion Bank from C$100.00 to C$102.00 in a research report on
Friday, May 27th. Stifel Nicolaus lowered their target price on shares of
Toronto-Dominion Bank from C$97.00 to C$93.00 in a report on Wednesday, July 13th.
Scotiabank lowered their target price on shares of Toronto-Dominion Bank from
C$102.00 to C$101.00 in a report on Thursday, August 18th. Finally, Credit
Suisse Group raised their price target on shares of Toronto-Dominion Bank from
C$102.00 to C$103.00 in a research note on Friday, May 27th. One research
analyst has rated the stock with a sell rating, eight have given a hold rating
and four have issued a buy rating to the company. According to MarketBeat,
Toronto-Dominion Bank currently has a consensus rating of “Hold” and a
consensus price target of $100.27. Read
more …
Downgrades:
V.F. (NYSE:VFC) was downgraded by investment analysts at Cowen from an "outperform" rating to a "market perform" rating in a research report issued to clients and investors on Monday, Briefing.com reports. They presently have a $50.00 price objective on the textile maker's stock, down from their prior price objective of $52.00. Cowen's price target indicates a potential upside of 9.77% from the stock's previous close.
VFC has been the topic of several other reports. Barclays
dropped their target price on V.F. to $46.00 in a research report on Tuesday,
August 9th. The Goldman Sachs Group cut their price objective on shares of V.F.
from $40.00 to $35.00 and set a "sell" rating on the stock in a
research report on Thursday, July 21st. UBS Group decreased their target price
on shares of V.F. from $65.00 to $55.00 in a research report on Friday, May
13th. Deutsche Bank Aktiengesellschaft cut their price target on V.F. from
$59.00 to $56.00 and set a "buy" rating on the stock in a report on
Monday, August 1st. Finally, Cowen lowered V.F. from an "outperform"
rating to a "market perform" rating in a report on Monday. Two
research analysts have rated the stock with a sell rating, thirteen have
assigned a hold rating and eight have given a buy rating to the company. Based
on data from MarketBeat.com, V.F. currently has an average rating of
"Hold" and an average price target of $58.56. Read
more …
Canadian National Railway (TSE:CNR) (NYSE:CNI) was downgraded by equities research analysts at Evercore ISI to a "hold" rating in a report released on Monday, Stock Target Advisor reports. They presently have a C$129.00 price target on the stock. Evercore ISI's target price suggests a potential downside of 20.71% from the company's previous close.
Several other equities research analysts also recently
issued reports on CNR. BMO Capital Markets upgraded shares of Canadian National
Railway from a "market perform" rating to a "buy" rating and
set a C$170.00 target price for the company in a research note on Wednesday,
May 18th. UBS Group cut their price objective on shares of Canadian National
Railway from C$184.00 to C$175.00 and set an "outperform" rating for
the company in a research report on Wednesday, July 27th. National Bankshares
raised their price objective on shares of Canadian National Railway from
C$160.00 to C$166.00 and gave the stock a "sector perform" rating in
a research report on Wednesday, July 27th. Cowen restated a "hold"
rating and set a C$127.00 price objective on shares of Canadian National
Railway in a research report on Wednesday, April 27th. Finally, Raymond James
set a C$175.00 price objective on shares of Canadian National Railway and gave
the stock a "market perform" rating in a research report on Thursday,
April 28th. One investment analyst has rated the stock with a sell rating,
fourteen have issued a hold rating and seven have assigned a buy rating to the
company. According to MarketBeat, the company presently has an average rating
of "Hold" and a consensus target price of C$153.23. Read
more …
BMO Capital Markets lowered shares of Bank of Nova Scotia (TSE:BNS) (NYSE:BNS) from an outperform rating to a market perform rating in a report issued on Wednesday, BayStreet.CA reports.
A number of other analysts also recently issued reports on
the stock. Fundamental Research downgraded shares of Bank of Nova Scotia from a
buy rating to a hold rating and set a C$84.50 price target on the stock. in a
report on Wednesday, June 8th. Cormark lifted their price target on shares of
Bank of Nova Scotia from C$91.00 to C$95.00 in a report on Wednesday. TD
Securities reduced their price objective on shares of Bank of Nova Scotia from
C$84.00 to C$83.00 and set a hold rating on the stock in a research report on
Tuesday. Stifel Nicolaus lifted their price objective on shares of Bank of Nova
Scotia from C$95.00 to C$97.00 in a research report on Thursday, May 26th.
Finally, CSFB reduced their price objective on shares of Bank of Nova Scotia
from C$85.00 to C$84.00 in a research report on Wednesday. Eleven equities
research analysts have rated the stock with a hold rating and three have issued
a buy rating to the stock. According to MarketBeat, the stock currently has an
average rating of Hold and an average price target of C$87.27. Read
more …
Raymond James cut shares of Medtronic (NYSE:MDT) from an outperform rating to a market perform rating in a report issued on Wednesday, The Fly reports.
Other analysts also recently issued reports about the stock.
Atlantic Securities downgraded shares of Medtronic from an overweight rating to
a neutral rating and lowered their price target for the stock from $125.00 to
$105.00 in a report on Wednesday, June 1st. Royal Bank of Canada decreased
their price objective on shares of Medtronic from $135.00 to $122.00 in a
report on Friday, May 27th. Needham & Company LLC downgraded shares of
Medtronic from a buy rating to a hold rating in a report on Friday, May 27th.
Sanford C. Bernstein reaffirmed a buy rating and set a $122.00 price objective
on shares of Medtronic in a report on Friday, May 20th. Finally, Wolfe Research
began coverage on shares of Medtronic in a report on Tuesday, July 5th. They
set an underperform rating and a $85.00 price objective on the stock. One
equities research analyst has rated the stock with a sell rating, eleven have
issued a hold rating and eleven have assigned a buy rating to the company.
Based on data from MarketBeat, Medtronic currently has a consensus rating of
Hold and an average target price of $116.00. Read
more …
Abbott Laboratories (NYSE:ABT) was downgraded by investment analysts at Erste Group Bank from a "buy" rating to a "hold" rating in a note issued to investors on Thursday, The Fly reports.
Other equities analysts have also issued research reports
about the company. Cowen decreased their price target on Abbott Laboratories
from $150.00 to $130.00 in a research report on Wednesday, July 13th. Wolfe
Research started coverage on Abbott Laboratories in a research note on Tuesday,
July 5th. They issued an "underperform" rating on the stock. UBS
Group lowered their target price on Abbott Laboratories from $142.00 to $128.00
and set a "buy" rating on the stock in a report on Wednesday, July
27th. BTIG Research decreased their price objective on Abbott Laboratories from
$130.00 to $126.00 and set a "buy" rating on the stock in a report on
Monday, July 18th. Finally, Evercore ISI cut their price objective on Abbott
Laboratories to $112.00 in a research report on Friday, July 22nd. One
investment analyst has rated the stock with a sell rating, three have assigned
a hold rating, eleven have issued a buy rating and one has assigned a strong
buy rating to the company. According to data from MarketBeat, the stock
presently has an average rating of "Moderate Buy" and a consensus
target price of $132.46. Read
more …
Union Pacific (NYSE:UNP) was downgraded by equities research analysts at Daiwa Capital Markets from an "outperform" rating to a "neutral" rating in a research report issued on Friday, The Fly reports. The analysts noted that the move was a valuation call.
A number of other equities research analysts have also
recently issued reports on the company. Evercore ISI reduced their price
objective on Union Pacific from $245.00 to $236.00 and set an
"in-line" rating for the company in a report on Tuesday, July 12th.
Raymond James cut their price target on Union Pacific from $285.00 to $250.00
and set a "strong-buy" rating for the company in a research note on
Friday, July 8th. Credit Suisse Group cut their price target on Union Pacific
to $252.00 in a research note on Friday, July 22nd. Morgan Stanley cut their
price target on Union Pacific from $210.00 to $207.00 and set an "equal
weight" rating for the company in a research note on Friday, July 22nd.
Finally, Citigroup cut Union Pacific from a "buy" rating to a
"neutral" rating and cut their price target for the company from
$287.00 to $235.00 in a research note on Thursday, May 19th. Thirteen research
analysts have rated the stock with a hold rating, six have issued a buy rating
and one has given a strong buy rating to the company's stock. According to data
from MarketBeat.com, the company has an average rating of "Hold" and
an average price target of $248.36. Read
more …
Comments
Post a Comment